Published in TB and Outbreaks Week, May 16th, 2000
J.D. Tobias of the University of Missouri retrospectively reviewed data on infants who were given caffeine for apnea associated with RSV ("Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants," Southern Medical Journal, 2000;93(3):294-296).
Seven infants were identified. Infants' ages ranged from 14 to 64 days; their weight was between 2.8 and 4.4 kgs, Tobias...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.